Stockreport

Hepion Pharmaceuticals Announces Dosing of First HBV Patient in 28-Day Study of CRV431

Hepion Pharmaceuticals, Inc.  (HEPA) 
Last hepion pharmaceuticals, inc. earnings: 11/14 05:17 pm Check Earnings Report
PDF EDISON, N.J., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a biopharmaceutical company focused on the development of therapeutic drugs [Read more]